GeneDx Holdings Corp. (WGS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
North Tower
Stamford, CT 06902
United States of America (the)
Phone
800 298 6470
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
1300
First IPO Date
November 04, 2020
| Name | Title | Pay | Year Born |
| Katherine A. Stueland | Chief Executive Officer & Director | 1.81M | 1976 |
| Bryan Dechairo | Chief Technology & Innovation Officer | 882,404 | 1973 |
| Kevin Feeley | Chief Financial Officer | 932,000 | 1981 |
| Mark A. Gardner | President | 0 | 1966 |
| Jami Biliboaca | Chief People Officer | 0 | N/A |
| Linda Genen | Chief Medical Officer | 0 | N/A |
| Lisa Gurry | Chief Business Officer | 0 | N/A |
| Melanie Duquette | Chief Growth Officer | 0 | N/A |
| Sabrina Dunbar | Director of Investor Relations & Communications | 0 | N/A |
| Heidi C. Chen | Chief Legal Officer | 0 | 1967 |
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.